![Robert Nicora](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Robert W.
Nicora has been President, Chief Executive Officer and Director of Synthetic Blood International, Inc. since March 1, 1998.
From 1994 through March 1998, he was Director of Scientific and Regulatory Services with Quintiles.
Mr. Nicora has over 30 years of experience in various laboratory, management and regulatory positions with pharmaceutical and medical device companies.
He holds BS in Chemistry.
Eerdere bekende functies van Robert Nicora
| Bedrijven | Functie | Einde |
|---|---|---|
| TENAX THERAPEUTICS, INC. | President | 20-11-2007 |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Hoofd Techniek/Wetenschap/O&O | 01-03-1998 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Tenax Therapeutics, Inc.
 Tenax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes pharmaceutical therapeutic products | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
